Retinitis Pigmentosa Clinical Trials in Beijing, Beijing Municipality
4 recruitingBeijing, Beijing Municipality, China
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients
Retinitis Pigmentosa
Zhongmou Therapeutics12 enrolled1 locationNCT06292650
Recruiting
Phase 1Phase 2
Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa
X-Linked Retinitis Pigmentosa (XLRP)
Frontera Therapeutics32 enrolled1 locationNCT06492850
Recruiting
Early Phase 1
Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
Retinitis Pigmentosa
Peking University Third Hospital9 enrolled1 locationNCT05805007
Recruiting
Early Phase 1
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
X-Linked Retinitis Pigmentosa
Frontera Therapeutics18 enrolled2 locationsNCT05874310